Publications
5808 Results
- Journal / Conference
- Gastroenterology Vol. 142,Issue 5, Suppl 1, p. S-115-S-116; Digestive Disease Week Annual Meeting, oral;
- Year
- 2012
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0701
Estimated one-year effectiveness and costs of six H. pylori test-and-treat strategies involving triple, concomitant or sequential drug regimens used with or without follow-up urea breath testing and rescue therapy in seven Latin American sites (SWOG trial S0701)
- Journal / Conference
- Gastroenterology Vol. 142, Issue 5, Supplement 1, Pages S-183-S-184, 2012; Digestive Disease Week Annual Meeting, oral presentation;
- Year
- 2012
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0701
Predictors of success of Helicobacter pylori eradication treatment in a multicentric randomized clinical trial (SWOG S0701)in Latin America
- Journal / Conference
- Gastroenterology Vol. 142, Issue 5, Supplement 1, page S-113; Digestive Disease Week Annual Meeting, oral presentation, plenary session);
- Year
- 2012
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- R9704
Predictive markers of gemcitabine treatment response in pancreas cancer: a pharmacogenomic pathyway approach
- Journal / Conference
- Society for Clinical Trials, abstr P110, p. 153 (program booklet); poster presentation;
- Year
- 2012
- Research Committee(s)
- Multiple sites and Outcomes and Comparative Effectiveness
Provision of coverage analysis in multi-site clinical trials particularly supports smaller, community-based practices
- Journal / Conference
- Clinical Cancer Research 18(2):336-341
- Year
- 2012
- Research Committee(s)
- Melanoma
- PMID
- PMID22142824
- PMC
- PMC3422891
New challenges in endpoints for drug development in advanced melanoma [PMID22142824; PMC3422891]
- Journal / Conference
- J Clin Oncol 30(suppl; abstr e16508); American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), publication only;
- Year
- 2012
- Research Committee(s)
- Multiple sites and Outcomes and Comparative Effectiveness
Strategies to increase efficiency in protocol development
- Journal / Conference
- Journal of Clinical Oncology 30 (suppl; abstr CRA6009); American Society of Clinical Oncology 2012 Annual Mtg (June 1-5, 2012, Chicago, IL), oral presentation;
- Year
- 2012
- Research Committee(s)
- Outcomes and Comparative Effectiveness
Patterns of decision-making about cancer clinical trial participation among online cancer treatment community: a collaboration between SWOG and NexCura
- Journal / Conference
- J Clin Oncol 30 (suppl; abstr 7570); American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), poster presentation;
- Year
- 2012
- Research Committee(s)
- Lung
Older patient participation in SWOG lung cancer trials: Comparative analysis from 1993 to 2008.
- Journal / Conference
- J Clin Oncol 30 (suppl;abstr 8504); American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), oral presentation;
- Year
- 2012
- Research Committee(s)
- Melanoma
- Study Number(s)
- S0008
Phase III trial of high dose interferon alpha- 2b versus cisplatin, vinblastine, DTIC plus IL2 and interferon in patients with high risk melanoma (SWOG S0008): an intergroup study of CALGB, COG, ECOG and SWOG.
- Journal / Conference
- J Clin Oncol 30 (suppl; abstr 8527); American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), poster discussion;
- Year
- 2012
- Research Committee(s)
- Melanoma
- Study Number(s)
- S0008